Follow Us TR

News Details

RedHill Biopharma Strengthens Coverage for Talicia® with Preferred Brand Position on Prime Therapeutics NetResults™ National Formulary

About Redhill Biopharma Ltd.
  • NASDAQ: $RDHL
  • Notified: $8.60
  • 07:00 EDT

Price Chart